Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Xingfa Chemicals Group is a Chinese publicly traded specialty chemicals manufacturer focused primarily on fine phosphorus chemicals, agrochemicals, fertilizers, organosilicon materials, electronic chemicals, and related industrial products. The company was founded in 1994, is headquartered in Yichang, Hubei, and is listed on the Shanghai Stock Exchange under stock code 600141. Its product portfolio includes food-grade, pharmaceutical-grade, and electronic-grade phosphates, as well as glyphosate, lithium iron phosphate, iron phosphate, dimethyl sulfoxide, and other sulfur- and phosphorus-based chemicals. While the company has some products used in pharmaceutical or food applications, it is not a biotech, pharma, or healthcare company; it is best characterized as a diversified chemical and materials enterprise with large-scale manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Xingfa Chemicals Group.